Genetic counselling in presymptomatic testing for Huntington's disease;Genetisk veiledning ved presymptomatisk testing for Huntingtons sykdom

Tidsskrift for den Norske Laegeforening

Volumn 120, Issue 20, 2000, Pages 2412-2416

  Helle, Johan Robert ^a   Braathen, Geir Julius ^a   Pedersen, Jan Christian ^a   Skodje, Tove ^a   Stokke, Bodil ^b   Berg, Kåre ^c  

^a Medisinsk Avdeling   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CASE REPORT; FEMALE; GENETIC COUNSELING; GENETIC PREDISPOSITION; GENETICS; HUMAN; HUNTINGTON CHOREA; LEGAL ASPECT; MALE; MEDICAL ETHICS; MIDDLE AGED; NORWAY; NUCLEOTIDE SEQUENCE; PEDIGREE; PREGNANCY; PRENATAL DIAGNOSIS; PSYCHOLOGICAL ASPECT; SOCIAL SUPPORT;

ADULT; AGED; DNA MUTATIONAL ANALYSIS; ETHICS, MEDICAL; FEMALE; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HUNTINGTON DISEASE; MALE; MIDDLE AGED; NORWAY; PEDIGREE; PREGNANCY; PRENATAL DIAGNOSIS; SOCIAL SUPPORT;

EID: 0034734216     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group. Cell 1993; 72: 971-83.
2. Gusella JF, MacDonald ME, Ambrose CM, Duyao MP. Molecular genetics of Huntington's disease. Arch Neurol 1993; 50: 1157-63.
3. ACMG/ASHG statement. Laboratory guidelines for Huntingdon disease genetic testing. The American College of Medical Genetics/American Society of Human Genetics Huntington Disease Genetic Testing Working Group. Am J Hum Genet 1998; 62: 1243-7.
4. Duyao M, Ambrose C, Myers R, Novelletto A, Persichetti F, Frontali M et al. Trinucleotide repeat length instability and age of onset in Huntington's disease. Nat Genet 1993; 4: 387-92.
5. Brinkman RR, Mezei MM, Theilmann J, Almqvist E, Hayden MR. The likelihood of being affected with Huntington disease by a particular age, for a specific CAG size. Am J Hum Genet 1997; 60: 1202-10.
6. Berg K. DNA-undersøkelser i familier med Huntingtons chorea. Tidsskr Nor Lægeforen 1991; 111: 815-7.
7. Norges offentlige utredninger. Mennesker og bioteknologi. Vedlegg 2. NOU 1991: 6. Oslo: Statens forvaltningstjeneste, Seksjon statens trykning, 1991: 162-70.
8. Guidelines for the molecular genetics predictive test in Huntington's disease. International Huntington Association (IHA) and the World Federation of Neurology (WFN) Research Group on Huntington's Chorea. Neurology 1994; 44: 1533-6.
9. Lov av 5.8. 1994, nr. 56 om medisinsk bruk av bioteknologi.
10. Lawson K, Wiggins S, Green T, Adam S, Bloch M, Hayden MR. Adverse psychological events occurring in the first year after predictive testing for Huntington's disease. The Canadian Collaborative Study Predictive Testing. J Med Genet 1996; 33: 856-62.
11. Bundey S. Few psychological consequences of presymptomatic testing for Huntington disease. Lancet 1997; 349: 4.
12. Bird TD. Outrageous fortune: the risk of suicide in genetic testing for Huntington disease. Am J Hum Genet 1999; 64: 1289-92.
13. Almqvist EW, Bloch M, Brinkman R, Craufurd D, Hayden M. A worldwide assessment of the frequency of suicide, suicide attempts, or psychiatric hospitalization after predictive testing for Huntington disease. Am J Hum Genet 1999; 64: 1293-1304.